Krisztina Kárpát, MD of Bayer Hungary, elaborates on the successful development of the affiliate in recent years, making progress in all three business units of pharma, consumer health, and crop science – soon to integrate Monsanto. As a leader with unique experience in finance, Ms Kárpát offers her insights into the strategies in cooperating with authorities to find mutual solutions for innovation access. Additionally, Dr Zsofia Tarjanyi, market access manager of the pharma business unit, elaborates on the affiliate’s activity in this area.
We have quite a significantly sized clinical trial team here in Hungary – even larger than our marketing team in fact
